The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study


TOMBAK A., Ucar M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN F., AKAY O. M., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.4, ss.273-280, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 4
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tjh.2015.0203
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.273-280
  • Anahtar Kelimeler: Azacitidine, Acute myeloid leukemia, Elderly, Bone marrow blasts, Prognostic factors, Overall survival, CONVENTIONAL CARE REGIMENS, INTERNATIONAL WORKING GROUP, ACUTE MYELOGENOUS LEUKEMIA, NEWLY-DIAGNOSED AML, OLDER PATIENTS, INTENSIVE CHEMOTHERAPY, MYELODYSPLASTIC SYNDROME, RESPONSE CRITERIA, AGE, CYTARABINE
  • İnönü Üniversitesi Adresli: Evet

Özet

Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts.